Non-adrenergic, non-cholinergic function in the human airway

Respiratory Medicine

Volumn 92, Issue 3, 1998, Pages 461-466

  Mackay, T W ^a   Hulks, G ^b   Douglas, N J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b RAIGMORE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPSAICIN; CHOLINERGIC RECEPTOR BLOCKING AGENT; PROPRANOLOL;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; BETA ADRENERGIC RECEPTOR BLOCKING; BRONCHODILATATION; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG RESISTANCE; MALE; NONADRENERGIC NONCHOLINERGIC NERVE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SYMPATHETIC TONE;

EID: 0031977741     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(98)90292-X     Document Type: Article

References (20)

1. Morrison JF, Pearson SB, Dean HG. Parasympathetic nervous system in nocturnal asthma. Br Med J 1988; 296: 1427-1429.
2. Barnes PJ. Neural control of airways in health and disease. Am Rev Respir Dis 1986; 134: 1289-1314.
3. Fuller RW, Dixon CMS, Barnes PJ. Bronchoconstric-tor response to inhaled capsaicin in humans. J Appl Physiol 1985; 58: 1080-1084.
4. Lammers J-WJ, Minette P, McCusker MT, Fan Chung K, Barnes PJ. Nonadrenergic bronchodilator mechanisms in normal human subjects in vivo. J Appl Physiol 1988; 64: 1817-1822.
5. Ichinose M, Inoue H, Miura M, Takishima T. Non-adrenergic bronchodilatation in normal subjects. Am Rev Respir Dis 1988; 138: 31-34.
6. Ellis JL, Undem BJ. Inhibition by L-NG-nitro-L-arginine of nonadrenergic - noncholinergic-mediated relaxations of human isolated central and peripheral airways. Am Rev Respir Dis 1992; 146: 1543-1547.
7. Ward JK, Belvisi MG, Fox AJ et al. Modulation of cholinergic neural bronchoconstriction by endogenous nitric oxide and vasoactive intestinal peptide in human airways in vitro. J Clin Invest 1993; 92: 736-742.
8. Mackay TW, Fitzpatrick MF, Douglas NJ. Non-adrenergic, non-cholinergic nervous system and overnight airway calibre in asthmatic and normal subjects. Lancet 1991; 338: 1289-1292.
9. Ewing DJ, Hume L, Campbell IW, Murray A, Neilson JMM, Clarke BF. Autonomic mechanisms in the initial heart rate response to standing. J Appl Physiol 1980; 49: 809-814.
10. Lammers J-WJ, Minette P, McCusker MT, Fan Chung K, Barnes PJ. Capsaicin induced bronchodilatation in mild asthmatic subjects: possible role of a noradrenergic inhibitory system. J Appl Physiol 1989; 67: 856-861.
11. Ryan GM, Latimer KM, Dolovich J, Hargreave FE. Bronchial responsiveness to histamine: relationship to diurnal variation of peak flow rate, improvement after bronchodilator, and airway calibre. Thorax 1982; 37: 423-429.
12. Thompson DC, Diamond L, Altiere RJ. Presynaptic alpha-adrenoceptor modulation of neurally mediated cholinergic excitatory and non-adrenergic, non-cholinergic inhibitory responses in guinea pig trachea. J Pharmacol Exp Ther 1990; 254: 306-311.
13. Verleden GM, Belvisi MG, Rabe KF, Miura M, Barnes PJ. Adrenoceptor agonists inhibit NANC neural bronchoconstrictor responses in vitro. J Appl Physiol 1993; 74: 1195-1199.
14. Grundstrom N, Wikberg RGG, Andersson JES. Inhibition of the excitatory non-adrenergic, non-cholinergic neuro-transmission in the guinea pig tracheobronchial tree mediated by alpha-2-adrenoceptors. Acta Pharmacol Toxicol 1984; 54: 8-14.
15. Stretton CD, Belvisi MB, Barnes PJ. Neuropeptide Y modulates non-adrenergic, non-cholinergic neurobronchoconstriction in vivo and in vitro. Neuropeptides 1990; 17: 163-170.
16. Micoud M-C, Jeanneret-Grosjean A, Cohen A, Amyot R. Reflex decrease of histamine induced broncho-constriction and laryngeal stimulation in asthmatic patients. Am Rev Respir Dis 1988; 138: 1548-1552.
17. Tattersfield AE, Leaver DG, Pride NB. The effect of β-adrenergic blockade and stimulation on normal human airways. J Appl Physiol 1973; 35: 613-619.
18. Richardson PS, Sterling GM. Effects of beta-adrenergic receptor blockade on airway conductance and lung volume in normal and asthmatic subjects. Br Med J 1969; iii: 143-145.
19. Sears MR, Taylor DR, Print CG et al. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 1990; 336: 1391-1396.
20. Spitzer W, Suissa S, Ernest P et al. The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med 1992; 326: 501-506.